12.07
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BriaCell Therapeutics : Investor Presentation (1Dec2025 Investor Presentation) - marketscreener.com
BriaCell Therapeutics (BCTXZ) Stock Analysis Report | Financials & Insights - Benzinga
Will BriaCell Therapeutics Corp. Equity Warrant stock outperform Dow Jones indexQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
BriaCell to present positive breast cancer therapy data at SABCS By Investing.com - Investing.com Australia
BriaCell Therapeutics (BCTXW) Stock Analysis Report | Financials & Insights - Benzinga
BriaCell Unveils Promising Clinical Data at 2025 SABCS - TipRanks
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell (BCTX) Shares Positive Clinical Results Ahead of 2025 S - GuruFocus
BriaCell (Nasdaq: BCTX) shares survival, biomarker data; Phase 3 interim readout 1H2026 - Stock Titan
Can BriaCell Therapeutics Corp. stock hit analyst price targetsMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
(BCT) Strategic Investment Report (BCT:CA) - news.stocktradersdaily.com
Bicara Therapeutics (BCTX) Releases Promising Early Data from Ca - GuruFocus
BriaCell files subsidiary financials and analysis with Canadian regulators By Investing.com - Investing.com Nigeria
BriaCell files subsidiary financials and analysis with Canadian regulators - Investing.com
BriaCell Therapeutics Corp Subsidiary Files Financial Statements - TradingView
(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com
What analysts say about BriaCell Therapeutics Corp stockEquity Performance Review & Fast Growing Portfolio Trading - earlytimes.in
BCTXZ Insider Trading - Quiver Quantitative
BriaCell Therapeutics Corp. (BCTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BriaCell Therapeutics to Present Promising Clinical Data at SABCS 2025 - The Globe and Mail
BriaCell to present positive cancer treatment data at breast cancer symposium By Investing.com - Investing.com Australia
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell to present positive cancer treatment data at breast cancer symposium - Investing.com
BriaCell Therapeutics Brief: Says to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS 2025 - marketscreener.com
BriaCell Therapeutics (NASDAQ: BCTX) Highlights Metastatic Breast Cancer Phase 2/3 Data - Stock Titan
How to Take Advantage of moves in (BCT) (BCT:CA) - news.stocktradersdaily.com
BriaCell Expands Phase 3 Study in Metastatic Breast Cancer - MSN
What analysts say about BriaCell Therapeutics Corp Equity Warrant stockDividend Stability Analysis & Exceptional Capital Trading - earlytimes.in
BriaCell to Present Key Clinical Data at SABCS 2025 - MSN
BriaCell and Receptor.AI Partner on AI- driven Small Molecule Cancer Therapeutics - MarketScreener
BriaCell (BCTX) Partners with Receptor.AI for Innovative Cancer Drug Development - GuruFocus
Briacell and Receptor.AI to collaborate on AI driven small molecule cancer therapeutics - MarketScreener
BriaCell and Receptor.AI Collaborate on AI-Driven Cancer Therapeutics - TipRanks
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics - The Manila Times
How BriaCell Therapeutics Corp. stock valuations compare to rivalsProfit Target & AI Forecasted Stock Moves - newser.com
Why analysts maintain buy rating on BriaCell Therapeutics Corp. (8BT0) stockSwing Trade & Trade Opportunity Analysis - newser.com
How buyback programs support BriaCell Therapeutics Corp. (8BT0) stock - newser.com
Why BriaCell Therapeutics Corp. (8BT0) stock trades below fair valueGold Moves & AI Enhanced Trading Alerts - newser.com
Published on: 2025-11-20 01:08:24 - newser.com
Why BriaCell Therapeutics Corp. (8BT0) stock remains top ratedMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Published on: 2025-11-19 11:18:19 - newser.com
Using portfolio simulators with BriaCell Therapeutics Corp. Equity Warrant includedTrend Reversal & Weekly High Conviction Ideas - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):